BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17703395)

  • 1. 30 years of ERCP and still the same problems?
    Guda NM; Freeman ML
    Endoscopy; 2007 Sep; 39(9):833-5. PubMed ID: 17703395
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
    Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
    Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endoscopic retrograde cholangiopancreatography: is it possible to effectively prevent ERCP-induced pancreatitis?].
    Il'chenko AA
    Eksp Klin Gastroenterol; 2008; (3):62-71. PubMed ID: 19145885
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
    Cooper ST; Slivka A
    Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only if needed and as minimally as possible. Animal model for post-ERCP pancreatitis: a step in the right direction.
    Guda N; Freeman M
    Endoscopy; 2008 Jun; 40(6):521-2. PubMed ID: 18543137
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the rate of post-ERCP pancreatitis not reduced by guide-wire cannulation?
    Park DH; Lee SS; Seo DW; Lee SK; Kim MH
    Endoscopy; 2008 Sep; 40(9):784; author reply 785. PubMed ID: 18773344
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
    Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Freeman ML
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for post-ERCP pancreatitis.
    Kadayifci A
    Endoscopy; 2008 Jan; 40(1):81; author reply 81. PubMed ID: 18210348
    [No Abstract]   [Full Text] [Related]  

  • 10. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
    Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
    Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevention, recognition and treatment of post-ERCP pancreatitis.
    Badalov N; Tenner S; Baillie J
    JOP; 2009 Mar; 10(2):88-97. PubMed ID: 19287099
    [No Abstract]   [Full Text] [Related]  

  • 12. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial ischemia, pancreatitis and ERCP.
    Roberts-Thomson IC; Teo E; Roberts-Thomson KC
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1469-70. PubMed ID: 20796138
    [No Abstract]   [Full Text] [Related]  

  • 14. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
    Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
    J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis.
    Bangarulingam SY; Gossard AA; Petersen BT; Ott BJ; Lindor KD
    Am J Gastroenterol; 2009 Apr; 104(4):855-60. PubMed ID: 19259076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial.
    Romagnuolo J; Hilsden R; Sandha GS; Cole M; Bass S; May G; Love J; Bain VG; McKaigney J; Fedorak RN
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):465-71; quiz 371. PubMed ID: 18304883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for ERCP-related complications: a prospective multicenter study.
    Wang P; Li ZS; Liu F; Ren X; Lu NH; Fan ZN; Huang Q; Zhang X; He LP; Sun WS; Zhao Q; Shi RH; Tian ZB; Li YQ; Li W; Zhi FC
    Am J Gastroenterol; 2009 Jan; 104(1):31-40. PubMed ID: 19098846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
    Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCP -- biliary.
    Kwan V
    Endoscopy; 2009 Jan; 41(1):74-8. PubMed ID: 19160160
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of post-ERCP pancreatitis: a little antacid might go a long way.
    Nagar AB; Gorelick F
    Gut; 2008 Nov; 57(11):1492-3. PubMed ID: 18941003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.